Chemoinformaics analysis of BENZYL (E)-2-METHYLBUT-2-ENOATE
| Molecular Weight | 190.242 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 18 |
| Exact Molecular Weight | 190.099 | nRing | 1 |
| Solubility: LogS | -3.999 | nHRing | 0 |
| Solubility: LogP | 3.625 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 30.9791 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.775 |
| Synth | 1.863 |
| Natural Product Likeliness | 0.542 |
| NR-PPAR-gamma | 0.928 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.719 |
| MDCK | 0.0000188 |
| BBB | 0.052 |
| PPB | 0.969628 |
| VDSS | 0.452 |
| FU | 0.0255771 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.87 |
| CYP2c19-inh | 0.862 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.69 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.594 |
| CYP2d6-sub | 0.87 |
| CYP3a4-inh | 0.602 |
| CYP3a4-sub | 0.222 |
| CL | 2.255 |
| T12 | 0.311 |
| hERG | 0.017 |
| Ames | 0.655 |
| ROA | 0.125 |
| SkinSen | 0.154 |
| Carcinogencity | 0.538 |
| EI | 0.709 |
| Respiratory | 0.167 |
| NR-Aromatase | 0.919 |
| Antiviral | No |
| Prediction | 0.650866 |